The S&P 500 Futures accelerated up sharply as Pfizer has announced its Phase 3 trial showed its experimental vaccine found to be over 90% effective in preventing Covid-19. Nasdaq 100 underperforms S&P500 and Dow Jones Industrial. Joe Biden was declared President elected over the weekend. However, President Trump didn't concede the election.
No major economic data are expected in North America today.
European indices are on a strongly bullish mood after Pfizer's announcement. The German Federal Statistical Office has posted September trade balance at 20.8 billion euros (vs 16 billion euros surplus expected). Europe Sentix Investor Confidence for November was released at -10, vs -15 expected and -8.3 in October. Bank of France Industrial Sentiment for October was published at 97, vs 90 expected.
Asian indices closed on a strong up move. In Japan, November Tankan Index was released at -13, above -28 expected.
WTI Crude Oil is posting a rebound. The total number of rotary rigs in the U.S. rose to 300 as of November 6 from 296 in the prior week.
US indices closed mixed on Friday with the Nasdaq (+0.04%) closing up, while the Dow Jones (-0.24%) and S&P 500 (-0.03%) closed down. Semiconductors & Semiconductor Equipment (+1.38%), Telecommunication Services (+0.88%) and Food & Staples Retailing (+0.79%) sectors were the best performers on the day, while Energy (-2.14%), Banks (-1.78%) and Consumer Durables & Apparel (-1.38%) sectors were the worst performers.
Approximately 75% of stocks in the S&P 500 Index were trading above their 200-day moving average and 68% were trading above their 20-day moving average. The VIX Index dropped 2.73pts (-9.9%) to 24.85, while Gold rose $2.99 (+0.15%) to $1952.65, and WTI Crude Oil fell $1.38 (-3.56%) to $37.41 at the close.
On the US economic data front, Change in Nonfarm Payrolls fell to 638K on month in October (580K expected), from a revised 672K in September. The Unemployment Rate dropped to 6.9% on month in October (7.6% expected), from 7.9% in September. Finally, Wholesale Inventories rose 0.4% on month in the September final reading (-0.1% expected), from -0.1% in the September preliminary reading.
Gold loses ground while the U.S dollar edges higher on Biden's win, rallying equity markets.
Gold fell 33.7 dollars (-1.73%) to 1917.65 dollars.
The dollar index rose 0.13pt to 92.354
U.S. Equity Snapshot
Pfizer (PFE) and BioNtech said their "vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis."
Source: TradingView, GAIN Capital
McDonald's (MCD), the global fast-food restaurant chain, jumps premarket as third quarter earnings beat estimates.
Apple (AAPL), a tech giant, suspended iPhone maker Pegatron following labour abuses in China. Separately, Apple is considering acquiring American podcast network Wondery for 300-400 million dollars, reported Bloomberg.
Berkshire Hathaway (BRK-A), an investment company, announced third quarter net income jumped 82% on year to 30.14 billion dollars while operating income dropped 30% to 5.48 billion dollars.
Biogen (BIIB), a pharmaceutical company, might dive after a FDA advisory panel voted against the company's Alzheimer's experimental treatment.
Peloton Interactive (PTON)'s, the interactive fitness platform, price target was raised to 160 dollars from 120 dollars at Bernstein.
This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.
GAIN Capital Singapore Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the GAIN Capital group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), GAIN Capital Singapore Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact GAIN Capital Singapore Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.
In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither GAIN Capital Singapore Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.
GAIN Capital Singapore Pte. Ltd. is not under any obligation to update this report.
Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit cityindex.com.sg for the complete Risk Disclosure Statement.
Cryptocurrencies are not legal tender currency and trading of derivatives on Cryptocurrencies are currently not covered under any regulatory regime in Singapore. Consequently, investors should be aware they do not have protection under the Securities and Futures Act (Cap. 289). Please ensure that you are fully aware of the risks.